CDKN2A and melanoma: Loss of p16 function is associated with increased susceptibility to a variety of malignancies, and germline mutations of p16INK4a have been found in up to 20-30% of melanoma-prone families.22-24 The INK4a-ARF locus also plays an important role in sporadic nonmelanoma skin cancers.